<html>
<head>PUBMED IDs for FBXO39</head>
<body bgcolor='#C5F0F2'><h1>FBXO39</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21338577/'>Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.</a> July 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24377578/'>Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.</a> January 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24377578/'>Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.</a> January 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27635108/'>Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.</a> September 17  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27635099/'>Irrational use of antibiotics and the risk of diabetes in Ghana.</a> April 11  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27635088/'>Administration of Non-Torsadogenic human Ether-Ã -go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.</a> September 17  2016<br></body></html>
